Article & News

Government plans to replace the Drugs & Cosmetics Act, 1940. This highlights a major regulatory shift. The Draft Drugs, Medical Devices & Cosmetics Bill, 2026

Companies reject the National Pharmaceutical Pricing Authority’s proposal that would place sole legal responsibility for overpricing on manufacturers while shielding retail chemists, hospitals and nursing

Dario Amodei recently made an unusually direct observation about the promises surrounding artificial intelligence and medicine:“At this point, saying that AI will cure cancer is

The draft Drugs, Medical Devices and Cosmetics Bill, 2026, proposes easing criminal prosecution for minor drug quality and regulatory lapses by allowing offences to be

Indian pharmaceutical firms have spent decades supplying American patients with affordable medicines. That dominance will be difficult to challenge, despite President Donald Trump’s threat to

According to the Department of Homeland Security, counterfeit drugs “threaten national security and public safety directly when introduced into government and critical infrastructure supply chains,

New Delhi: India’s pharmaceutical industry should treat the proposed US tariffs on imported generic medicines as a wake-up call to reduce dependence on a single

India became the phar­macy of the world by sup­ply­ing afford­able medi­cines to more than 200 coun­tries, dom­in­at­ing the global mar­ket for gen­eric drugs and pro­du­cing

India’s pharmaceutical industry has achieved extraordinary scale. We are the world’s third-largest producer by volume, supply around 20 per cent of global generic medicines, and

A significant development in diabetes care has arrived in India.Novo Nordisk has launched Awiqli (insulin icodec), a once-weekly basal insulin designed to provide insulin coverage